Will Public Disclosure of Sourcing and Mfg Info Improve the US Pharma Supply Chain?
By
At the request of Congress, the National Academies of Sciences, Engineering, and Medicine issued recommendations to improve the resiliency of the US pharma supply chain, including public disclosure of sourcing and manufacturing information.
Supply-Chain Digitalization: Senior Executives Weigh in on the Opportunities and Challenges
By
Increasing the use of digital technologies, such as artificial intelligence, blockchain, and predictive analytics in supply-chain operations is a priority for many executives. Senior executives weigh in on the opportunities and challenges.